Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

8.73
Delayed Data
As of 3:09pm ET
 -0.42 / -4.59%
Today’s Change
8.31
Today|||52-Week Range
18.94
-48.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.00--76.7K153.3K
 
 
 
 
Operating ExpensesGross Income0.000.00-76.7K-153.3K
 
 
 
General Expenses2.7M6.5M24.0M29.2M
 
 
 
 
 
Research And Development1.6M3.4M16.2M21.2M
 
 
 
 
 
Total Operating Expenses2.7M6.5M24.1M29.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-6.5M-24.1M-29.3M
 
 
 
 
 
Extraordinary Credit0.000.0030.4K0.00
 
 
Extraordinary Charge-9.7K0.000.000.00
 
 
Interest Expense On Debt98.6K118.8K516.9K0.00
 
 
 
 
Other Expenses46.7K301.6K321.3K338.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-6.3M-24.2M-28.8M
 
 
 
 
 
Net Income-2.8M-6.3M-24.2M-28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.0M7.5M10.3M12.9M
 
 
 
 
 
Shares To Calculate EPS Diluted7.0M7.5M10.3M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$1.82-$2.35-$2.23
 
 
 
 
 
EPS Diluted-$0.40-$0.84-$2.35-$2.23